Gilad E. Amiel, MD
Chairman, Department of Urology
RAMBAM HealthCare Campus
Haifa, Israel

Dr. Gilad E. Amiel is a graduate of the Ben-Gurion University Medical School in Beer-Sheva, Israel, and is a Captain in the Israeli Defense Forces (IDF)
He completed a residency in Urology at the Bnai-Zion Medical Center in Haifa, Israel. During that time he dedicated two years to basic science research (1998-2000). Dr. Amiel served as a research fellow at the Laboratory for Tissue Engineering and Cellular Therapeutics, Department of Urology at Children’s Hospital, Harvard Medical School in Boston, under the supervision of Dr. Anthony Atala. Upon completion of his urologic residency in Israel in 2003, he pursued a combined clinical and research fellowship in urologic oncology and minimally invasive surgery at the Scott Department of Urology, Baylor College of Medicine, in Houston, Texas (2004-2006). At Baylor he established a tissue engineering laboratory that focuses on translational research in genitourinary reconstruction. Thereafter, Dr. Amiel joined the faculty at Baylor in 2007 and was an Associate Professor, Director of Education, and the Director of the Laboratory for Genitourinary Tissue Engineering in the Scott Department of Urology at Baylor. In February, 2015 he accepted the position of Chairman, Department of Urology at Rambam Health Care Campus, Technion Faculty of Medicine in Haifa, Israel. He also maintained a position of adjunct Associate Professor at the Scott Department of Urology, Baylor College of Medicine. Dr Amiel received the Clinical Research Institute of Rambam  (CRIR) award and established the Laboratory for Genitourinary Research with a full-time PhD at the Clinical Research Institute at Rambam.

Dr. Amiel’s clinical practice consists of urologic oncology and genitourinary reconstruction. He performs robotic, laparoscopic, and open surgery for bladder, kidney, prostate, testis and penile cancer, including robotic cystectomy, robotic partial nephrectomy, robotic prostatectomy, minimally invasive & focal therapy for prostate cancer, salvage and complex reconstructive urinary operations. Dr. Amiel’s basic research focuses on genitourinary reconstruction utilizing biological matrices and novel treatments for bladder cancer. His clinical research projects focus on treatments of bladder cancer, prostate cancer, and cancer education.

Dr. Amiel received several teaching and education awards and till recently (10/2015) served as the president of the American Association for Cancer Education (AACE). He currently serves on the executive council and is the treasurer of the European Association for Cancer Education (EACE). He recently hosted EACE 31st annual meeting in April, 2018 in Haifa. Prof. Amiel is a member of the American Urological Association (AUA), Urology Research Foundation (URS), Bladder Cancer Advocacy Network (BCAN), Israel Medical Association (IMA), Israeli Association for Medical Education and is the director of CME for the Northern Israeli Urology Forum. He is the associate editor of the Journal of Cancer Education and a reviewer for several urological, educational, and bioengineering journals. He received thus far 17 grants, including a NIH-SBIR Grant totaling over 3 Million Dollars and was PI or co- investigator in numerous clinical trials. He has co-authored over 70 peer-reviewed publications and  book chapters.